View in EDS HTML Full Text PDF Full Text

GPR35-mediated metabolic reprogramming promotes tumorigenesis in digestive cancers.

Saved in:
Bibliographic Details
Title: GPR35-mediated metabolic reprogramming promotes tumorigenesis in digestive cancers.
Authors: Wang F; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Ding XX; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Su TH; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Cao J; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Li FQ; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China., Dong ZS; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China., Guo XZ; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China., Zhang Y; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China., Chen Y; State Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China., Yang DH; New York College of Traditional Chinese Medicine, Mineola, NY, United States., Luo P; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
Source: Frontiers in immunology [Front Immunol] 2025 Dec 12; Vol. 16, pp. 1668471. Date of Electronic Publication: 2025 Dec 12 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41459506
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: GPR35-mediated metabolic reprogramming promotes tumorigenesis in digestive cancers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Ding+XX%22">Ding XX</searchLink>; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Su+TH%22">Su TH</searchLink>; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Cao+J%22">Cao J</searchLink>; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Li+FQ%22">Li FQ</searchLink>; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Dong+ZS%22">Dong ZS</searchLink>; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Guo+XZ%22">Guo XZ</searchLink>; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Zhang+Y%22">Zhang Y</searchLink>; School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang, China.<br /><searchLink fieldCode="AU" term="%22Chen+Y%22">Chen Y</searchLink>; State Key Laboratory of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China.<br /><searchLink fieldCode="AU" term="%22Yang+DH%22">Yang DH</searchLink>; New York College of Traditional Chinese Medicine, Mineola, NY, United States.<br /><searchLink fieldCode="AU" term="%22Luo+P%22">Luo P</searchLink>; Cancer Research Center, The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Dec 12; Vol. 16, pp. 1668471. <i>Date of Electronic Publication: </i>2025 Dec 12 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41459506
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1668471
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1668471
    Titles:
      – TitleFull: GPR35-mediated metabolic reprogramming promotes tumorigenesis in digestive cancers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wang F
      – PersonEntity:
          Name:
            NameFull: Ding XX
      – PersonEntity:
          Name:
            NameFull: Su TH
      – PersonEntity:
          Name:
            NameFull: Cao J
      – PersonEntity:
          Name:
            NameFull: Li FQ
      – PersonEntity:
          Name:
            NameFull: Dong ZS
      – PersonEntity:
          Name:
            NameFull: Guo XZ
      – PersonEntity:
          Name:
            NameFull: Zhang Y
      – PersonEntity:
          Name:
            NameFull: Chen Y
      – PersonEntity:
          Name:
            NameFull: Yang DH
      – PersonEntity:
          Name:
            NameFull: Luo P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 12
              Text: 2025 Dec 12
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1